PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
36.07%
Net income growth under 50% of BB's 74.17%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
-30.51%
Negative yoy D&A while BB is 24.25%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-99.12%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
No Data
No Data available this quarter, please select a different quarter.
-37.18%
Both reduce yoy usage, with BB at -66.58%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-37.18%
Both reduce yoy usage, with BB at -68.74%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
680.25%
Some yoy increase while BB is negative at -60.44%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
27.33%
Operating cash flow growth at 50-75% of BB's 44.94%. Martin Whitman would worry about lagging operational liquidity vs. competitor.
38.83%
Some CapEx rise while BB is negative at -733.02%. John Neff would see competitor possibly building capacity while we hold back expansions.
97.67%
Acquisition spending well above BB's 100.00%. Michael Burry would suspect heavier integration risk or short-term free cash flow drain vs. competitor.
-33.51%
Negative yoy purchasing while BB stands at 100.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
11.94%
Below 50% of BB's 8753.82%. Michael Burry would see minimal near-term inflows vs. competitor’s liquidation approach.
No Data
No Data available this quarter, please select a different quarter.
-4064.44%
We reduce yoy invests while BB stands at 118.40%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
-4.92%
Negative yoy issuance while BB is 116.13%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
13.92%
Buyback growth below 50% of BB's 100.00%. Michael Burry suspects fewer capital returns to shareholders vs. competitor, unless expansions hold higher ROI.